Neutropenic enterocolitis (typhi litis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature

被引:24
作者
D'Amato, G
Lima, CR
Mahany, JJ
Muro-Cacho, C
Haura, EB
机构
[1] H Lee Moffit Canc Ctr & Res Inst, Expt Therapeut Program, Tampa, FL 33612 USA
[2] H Lee Moffit Canc Ctr & Res Inst, Thorac Oncol Program, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA
[4] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA
[5] Univ Miami, Sylvester Canc Ctr, Dept Med, Div Hematol Oncol, Miami, FL 33152 USA
关键词
typhlitis; neutropenic; enterocolitis; lung; cancer; taxanes; chemotherapy;
D O I
10.1016/j.lungcan.2003.11.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neutropenic enterocolitis (NE) is an unusual acute complication of neutropenia, most often associated with leukemia and lymphoma which is characterized by segmental cecal and ascending colon ulceration that may progress to necrosis, perforation, and septicemia. We present a case of neutropenic enterocolitis in a patient with non-small-cell lung cancer who received docetaxel and flavopiridol as part of a phase I clinical trial and review cases in the literature where docetaxel was involved. Given the increased use of docetaxel and other taxanes in the treatment of advanced lung cancer, physicians should be aware of this potential toxicity of therapy. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:381 / 390
页数:10
相关论文
共 54 条
[1]  
ABBASOGLU O, 1993, SURGERY, V113, P113
[2]   Neutropenic enterocolitis. [J].
Bavaro M.F. .
Current Gastroenterology Reports, 2002, 4 (4) :297-301
[3]   Typhlitis associated with docetaxel treatment [J].
Cardenal, F ;
Montes, A ;
Llort, G ;
Segui, J ;
Mesia, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (15) :1078-1079
[4]   Neutropenic enterocolitis in patients with acute leukemia: Prognostic significance of bowel wall thickening detected by ultrasonography [J].
Cartoni, C ;
Dragoni, F ;
Micozzi, A ;
Pescarmona, E ;
Mecarocci, S ;
Chirletti, P ;
Petti, MC ;
Meloni, G ;
Mandelli, F .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :756-761
[5]  
D'Souza S, 2000, SOUTHERN MED J, V93, P218
[6]   NECROTIZING COLITIS IN PATIENTS WITH CANCER [J].
DOSIK, GM ;
LUNA, M ;
VALDIVIESO, M ;
MCCREDIE, KB ;
GEHAN, EA ;
GILEXTREMERA, B ;
SMITH, TL ;
BODEY, GP .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (04) :646-656
[7]  
ETTINGHAUSEN SE, 1993, SURG CLIN N AM, V73, P993
[8]  
Fisherman J S, 1993, J Natl Cancer Inst Monogr, P189
[9]   Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer [J].
Fisherman, JS ;
Cowan, KH ;
Noone, M ;
Denicoff, A ;
Berg, S ;
Poplack, D ;
Balis, F ;
Venzon, D ;
McCabe, M ;
Goldspiel, B ;
Chow, C ;
Ognibene, FP ;
OShaughnessy, J .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :774-782
[10]   Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group [J].
Fossella, F ;
Pereira, JR ;
von Pawel, J ;
Pluzanska, A ;
Gorbounova, V ;
Kaukel, E ;
Mattson, KV ;
Ramlau, R ;
Szczesna, A ;
Fidias, P ;
Millward, M ;
Belani, CP .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3016-3024